An Open-label, Sequential, 3-period Study to Assess the Effects of Diltiazem on the Pharmacokinetics of Naloxegol in Healthy Subjects

Trial Profile

An Open-label, Sequential, 3-period Study to Assess the Effects of Diltiazem on the Pharmacokinetics of Naloxegol in Healthy Subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 17 Dec 2015

At a glance

  • Drugs Naloxegol (Primary) ; Diltiazem
  • Indications Constipation; Hypertension; Ischaemic heart disorders
  • Focus Pharmacokinetics
  • Most Recent Events

    • 17 Dec 2015 Results of this and other two trials (see profile 212872 and 212872) were published in the Journal of Clinical Pharmacology
    • 04 Jun 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
    • 15 May 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top